WXSH0102

· Cisen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WXSH0102, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients [Phase 2]